These therapeutic effects of both biologics are of particular importance in the case of steroid-requiring asthma, as controlled studies have shown that the use of anti-IL-5 or anti-IL-5Rα antibodies enables a reduction or complete discontinuation of systemic corticosteroids [1, 13, 16]. This evidence concerns the gene IL5RA and asthma.